NO944852L - Proteinoid carriers and processes for their preparation and use - Google Patents
Proteinoid carriers and processes for their preparation and useInfo
- Publication number
- NO944852L NO944852L NO944852A NO944852A NO944852L NO 944852 L NO944852 L NO 944852L NO 944852 A NO944852 A NO 944852A NO 944852 A NO944852 A NO 944852A NO 944852 L NO944852 L NO 944852L
- Authority
- NO
- Norway
- Prior art keywords
- proteinoid carriers
- preparation
- processes
- carriers
- proteinoid
- Prior art date
Links
- 239000000969 carrier Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 238000006303 photolysis reaction Methods 0.000 abstract 1
- 230000015843 photosynthesis, light reaction Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbedrede proteinoide bærere og fremgangsmåter for fremstilling derav og anvendelse som orale leverlngssystemer for farmasøytlske midler er beskrevet. Proteinoide bærere er oppløselige Innenfor valgt pH-onrådet l mage/tarm- kanalen og utviser forsterket stabilitet overfor minst fotolyse eller dekomponering over tid. Proteinoide bærere blir fremstilt fra protelnolder som har mellom 2 og 20 aminosyrer og som har en molekylvekt på mellom omtrent 250 og 2400 dalton.Improved proteinoid carriers and methods for their preparation and use as oral delivery systems for pharmaceutical agents are described. Proteinoid carriers are soluble Within the selected pH range in the gastrointestinal tract and exhibit enhanced stability to at least photolysis or decomposition over time. Proteinoid carriers are prepared from protein nodes having between 2 and 20 amino acids and having a molecular weight of between about 250 and 2400 daltons.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89890992A | 1992-06-15 | 1992-06-15 | |
| US07/920,346 US5443841A (en) | 1992-06-15 | 1992-07-27 | Proteinoid microspheres and methods for preparation and use thereof |
| US08/076,803 US5578323A (en) | 1992-06-15 | 1993-06-14 | Proteinoid carriers and methods for preparation and use thereof |
| PCT/US1993/005723 WO1993025583A2 (en) | 1992-06-15 | 1993-06-15 | Proteinoid carriers and methods for preparation and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944852D0 NO944852D0 (en) | 1994-12-14 |
| NO944852L true NO944852L (en) | 1995-02-10 |
Family
ID=27491290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944852A NO944852L (en) | 1992-06-15 | 1994-12-14 | Proteinoid carriers and processes for their preparation and use |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO944852L (en) |
-
1994
- 1994-12-14 NO NO944852A patent/NO944852L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO944852D0 (en) | 1994-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945912A0 (en) | Proteinoid carriers and methods for their preparation and their use | |
| EP0340741A3 (en) | Polyethylene glycol derivatives, modified peptides and production thereof | |
| NZ232853A (en) | Heterocyclyl-substituted-fluorobenzoyl derivatives and pharmaceutical compositions | |
| RU95122664A (en) | Amplification of the Vitamin B12 Absorption System Using Polymers | |
| ATE210424T1 (en) | DELAYED RELEASE OF PEPTIDES FROM PHARMACEUTICAL COMPOSITIONS | |
| BR9809138A (en) | Conjugate and method to increase the transport of a selected compound across a biological membrane | |
| ATE309197T1 (en) | METHOD FOR PRODUCING ALKYLATED SALICYLAMIDES | |
| EP0528312A3 (en) | Cyclic peptides and use thereof | |
| FI832355L (en) | 9- (2-HYDROXYETOXIMETYL) guanidine derivate | |
| AU563230B2 (en) | Pepstatine derivatives | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| IE872983L (en) | Peptides | |
| EP0228192A3 (en) | Renin-inhibitory oligopeptides, their preparation and use | |
| ES8703488A1 (en) | ZNS-active peptides acting on the cholinergetic system. | |
| ATE59554T1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON MERCAPTOETHANESULPHONIC ACIDS, ORGANIC DERIVATIVES OF MERCAPTOETHANESULPHONIC ACIDS AND PROCESSES FOR THEIR PREPARATION. | |
| NO20003832L (en) | Method of spray drying pharmaceutical formulations containing amino acid-based materials | |
| AU8230187A (en) | N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration | |
| MY114693A (en) | Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them | |
| KR930703348A (en) | Factor II (IIa) Inhibitors | |
| IT8821046A0 (en) | BIODEGRADABLE POLYAMIDE FILMS AND PRODUCTS OBTAINED FROM SAID POLYAMIDE AND PROCEDURE FOR ITS PREPARATION. | |
| ATE252598T1 (en) | STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND PREPARATIONS CONTAINING THEM | |
| IT8723007A0 (en) | PHARMACEUTICAL COMPOSITIONS FOR ORAL USE WITH BILE ACIDS SEQUESTRATION ACTIVITY CONTAINING CHOLESTYRAMINE AS THE ACTIVE INGREDIENT, AND PROCEDURE FOR PREPARING THEM | |
| RU93049678A (en) | SUSTAINABLE WATER-SOLUBLE VETERINARY PRODUCT AND METHOD FOR PRODUCING IT | |
| ATE135708T1 (en) | DERIVATIVES OF 10,11,12,13-TETRA-HYDRODESMYCOSINE, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE IN THE PRODUCTION OF MEDICINAL PRODUCTS |